Julie Wolf

622 total citations
9 papers, 541 citations indexed

About

Julie Wolf is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Julie Wolf has authored 9 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Julie Wolf's work include Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Julie Wolf is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Julie Wolf collaborates with scholars based in United States, Germany and China. Julie Wolf's co-authors include Warren J. Leonard, Flossie Wong‐Staal, Nikki J. Holbrook, Sharon L. Cross, Mark B. Feinberg, Suzanne Ostrand‐Rosenberg, Jacobus J. Bosch, Minu K. Srivastava, Bruce R. Ksander and Stephen J. Freeland and has published in prestigious journals such as Cell, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Julie Wolf

9 papers receiving 533 citations

Peers

Julie Wolf
Chloé Journo France
Sharon L. Cross United States
Frank W. Ruscetti United States
Shao-Cong Sun United States
Mitsuaki Yoshida Japan
Takaharu Ueno Japan
Fabian Vandermeers Belgium
Luca Casareto United States
Laurent Dianoux France
Dai Fujikawa Japan
Chloé Journo France
Julie Wolf
Citations per year, relative to Julie Wolf Julie Wolf (= 1×) peers Chloé Journo

Countries citing papers authored by Julie Wolf

Since Specialization
Citations

This map shows the geographic impact of Julie Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Wolf more than expected).

Fields of papers citing papers by Julie Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Wolf. The network helps show where Julie Wolf may publish in the future.

Co-authorship network of co-authors of Julie Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Wolf. A scholar is included among the top collaborators of Julie Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Wolf. Julie Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
3.
Haile, Samuel, et al.. (2011). Tumor cell Programmed Death Ligand-1-mediated T cell suppression is overcome by co-expression of CD80 (66.29). The Journal of Immunology. 186(1_Supplement). 66.29–66.29. 1 indexed citations
4.
Haile, Samuel, Jacobus J. Bosch, Minu K. Srivastava, et al.. (2011). Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80. The Journal of Immunology. 186(12). 6822–6829. 70 indexed citations
5.
Bosch, Jacobus J., Sarah Reid, Minu K. Srivastava, et al.. (2009). Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. Cancer Immunology Immunotherapy. 59(1). 103–112. 16 indexed citations
6.
Wu, Gang, et al.. (2006). Simplified gene synthesis: A one-step approach to PCR-based gene construction. Journal of Biotechnology. 124(3). 496–503. 48 indexed citations
7.
Halden, N F, Julie Wolf, & Warren J. Leonard. (1989). Identification of a novel site specific endonuclease produced byMycoplasma fermentans: discovery while characterizing DNA binding proteins in T lymphocyte cell lines. Nucleic Acids Research. 17(9). 3491–3499. 6 indexed citations
8.
Cross, Sharon L., Mark B. Feinberg, Julie Wolf, et al.. (1987). Regulation of the human interleukin-2 receptor α chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 49(1). 47–56. 384 indexed citations
9.
Hays, John B., Julie Wolf, & Robert J. Zagursky. (1983). NONIDEAL STATISTICS AND POSITIVE CORRELATION IN PHAGE RECOMBINATION: STUDIES WITH Λ TANDEM DUPLICATION PHAGES. Genetics. 105(4). 781–799. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chloé Journo Breakdown of academic impact, for papers by Sharon L. Cross Breakdown of academic impact, for papers by Frank W. Ruscetti Breakdown of academic impact, for papers by Shao-Cong Sun Breakdown of academic impact, for papers by Mitsuaki Yoshida Breakdown of academic impact, for papers by Takaharu Ueno Breakdown of academic impact, for papers by Fabian Vandermeers Breakdown of academic impact, for papers by Luca Casareto Breakdown of academic impact, for papers by Laurent Dianoux Breakdown of academic impact, for papers by Dai Fujikawa
Rankless by CCL
2026